SARS-CoV-2 Virucidal Efficacy 测试

Before any label claims declaring the ability to kill specified pathogens can be approved by regulatory agencies, proof of efficacy data must be generated. This regulatory requirement includes label claims against viruses such as SARS-CoV-2, 新型冠状病毒肺炎的病原体.

As 新型冠状病毒肺炎 variants rapidly emerge and circulate globally, proof of efficacy against specified pathogens has become particularly important during the 全球大流行. Some of the most prevalent 新型冠状病毒肺炎 variants include U.K. (B.1.1.7)， d (B).1.617.2)和欧米克隆(B.1.1.529). In keeping with our mission of making tomorrow safer than 今天, im体育APP offers efficacy testing using these strains as well as the initial Wuhan strain of SARS-CoV-2 to support label claims. This includes testing to EPA performance criteria used to evaluate the effectiveness of disinfectant products used for the sanitation of public areas to protect the public against 新型冠状病毒肺炎.

With one of only a few GLP-compliant Biosafety Level 3 (BSL-3) labs in the country, we have been instrumental in helping our clients combat this public health crisis. Our expanded 新型冠状病毒肺炎 efficacy testing services and BSL-3 capabilities have ensured im体育APP will continue helping our partners to fight this evolving pandemic, as well as combat future public health threats.

Virucidal efficacy testing for SARS-CoV-2 (causative agent of 新型冠状病毒肺炎)

Since the start of the pandemic, im体育APP has conducted countless tests to evaluate the effectiveness of medical, 工业, and consumer disinfectants for developers, 制造商, and marketers of infection control products to support regulated claims against the SARS-CoV-2 virus. We offer the following test methods for testing products against SARS-CoV-2, the causative agent of 新型冠状病毒肺炎. As new methods continue to be added rapidly for SARS-CoV-2 virus disinfectant testing for label claims, 请 查询 if the methods detailed below do not meet your needs.

悬架测试

im体育APP offers SARS-CoV-2有效性检测 to established suspension based test methods, 包括: 

• ASTM E1052 Standard Practice for Efficacy of 抗菌 Agents Against Viruses in Suspension
• 见en 14476

硬表面试验

Our knowledgeable antimicrobial experts test products for SARS-CoV-2 efficacy to support label claims according to established hard surface based testing methods, 包括: 

• ASTM E1053 Standard Practice for Efficacy of Virucidal Agents Intended for Inanimate 环境 Surfaces
• Bs en 16777

处理品检验

We offer SARS-CoV-2有效性检测 of treated articles for label claims and product registration to the following methodology: 

• Tm 100/ aatcc 100
• Jis 2801/ iso 21702

剩余的测试

im体育APP's antimicrobial testing experts carry out residual efficacy testing for claims against SARS-CoV-2 to EPA guidance: 

• 残余杀毒活性

自定义或设备测试

Our team can work with you to develop custom protocols to meet your testing needs. 要探索自定义协议， 与专家取得联系 今天.

im体育APP优势

主要开发人员, 制造商, and marketers of infection control products with support regulated claims against the SARS-CoV-2 virus continue to rely on im体育APP’s regulatory-compliant, comprehensive SARS-CoV-2 virucidal efficacy testing to support product registration. Our team of experienced scientists stay up to date with the latest scientific breakthroughs, 公共卫生需求, 监管指导, providing industry-leading support to those dedicated to combating the global 新型冠状病毒肺炎 pandemic and other public health crises.

For more information about im体育APP’s SARS-CoV-2 virucidal efficacy testing or for more information about our BSL-3 lab, im体育APP 今天.